WEIGHT LOSS PROGRAM IN BOYNTON BEACH, FL
WEIGHT LOSS PROGRAM
Are you looking to reduce weight and start to feel recharged? A prescription weight loss program is the solution for you. Before starting this program, you’ll be evaluated to ensure that this is a safe option. At your first appointment, we’ll examine your body mass index (BMI) before treatment begins and collect your medical history. This weight loss program combines a prescription weight loss medication (Phentermine) with Lipotropic Injections to achieve maximum weight reduction. The Lipotropic Injections will aid the fat reduction process by Live Vibrant Wellness And Aesthetics.
We’re always here to discuss your options. We speak Spanish and English! You’ll communicate freely with practitioners that speak both languages.
We offer monthly wellness consultations and blood work if necessary. You may get a Phentermine prescription medication or Lipotropic injections. We’ll determine which is suited for you during the consultation.
Our program includes:
Phentermine is a prescription medication that helps you reduce weight by decreasing your hunger or making you feel full longer. It’s indicated for patients who are obese and who weren’t able to lose enough weight with only diet and exercise. We’ll determine if you’re a great candidate for this prescription medication at your consultation.
Lipotropic Injections give you a slim appearance and reduce your weight while boosting your stamina. These shots consist of three essential amino acids that diminish fat cells.
The mix of L-Carnitine, B-Complex, and MIC decreases fat deposits, improves metabolism, converts fat into energy, and optimizes cardiovascular health. These injectable t
arget areas such as the chin, neck, hips, buttocks, stomach, arms, and thighs.
What is Semaglutide and Tirzepatide ?
Semaglutide and Tirzepatide are injectable medications, initially developed to treat type 2 diabetes, that have been found to promote weight loss. Semaglutide, marketed as Ozempic and Wegovy, mimics a hormone that regulates insulin and reduces appetite, thus leading to significant weight loss by reducing food intake. In 2021, the U.S. FDA approved a high-dose version of Semaglutide (Wegovy) specifically for weight management in adults with obesity or overweight who have at least one weight-related condition and have previously failed to lose weight with diet and exercise.
Tirzepatide, on the other hand, is a dual GIP and GLP-1 receptor agonist affecting both the pancreas and the brain. This dual mechanism aids in controlling blood sugar levels, reducing appetite, and promoting weight loss. As of September 2021, Tirzepatide was being studied for its potential effects on weight loss but hadn’t yet received specific approval for this use. Both medications are most effective when used alongside a healthy diet and regular exercise, which should be administered under medical supervision.
We offer a :
Frequently Asked Questions
Suppose you have a BMI of 27 kg/m with medical conditions such as diabetes, hypertension, obstructive sleep apnea, or high cholesterol. In that case, you’re a great candidate for this program.
The FDA has approved all the medications we prescribe for long-term use.
Most patients achieve losing five to twenty pounds each month.
You’ll get a lower BMI and improve obesity-related health conditions, such as type two diabetes, high blood pressure, sleep apnea, reflux disease, joint aches, fatty liver disease, and lowered cancer risk.